Maximum quantity allowed is 999
Please select the quantity
CAS RN: 57149-07-2 | Product Number: N0832
Naftopidil
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- 1-[4-(2-Methoxyphenyl)piperazinyl]-3-(1-naphthyloxy)propan-2-ol
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 5G |
₹11,700.00
|
2 | ≥100 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | N0832 |
Purity / Analysis Method 
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__4H__2__8N__2O__3 = 392.50 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 57149-07-2 |
| Reaxys Registry Number | 629965 |
| PubChem Substance ID | 87560652 |
| SDBS (AIST Spectral DB) | 52403 |
| Merck Index (14) | 6356 |
| MDL Number | MFCD00242741 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 125.0 to 129.0 °C |
Properties (reference)
| Melting Point | 127 °C |
| Solubility in water | Insoluble |
GHS
Related Laws:
| RTECS# | TL9336500 |
Transport Information:
Application
α1アドレナリン受容体のα1D とα1Aサブタイプ選択的アンタゴニスト，ナフトピジル
Naftopidil is an α1D and α1A subtype-selective α1-adrenoceptor antagonist. The α1-adrenergic receptor is a G protein-coupled receptor (GPCR) associated with the Gq heterotrimeric G-protein. The receptor consists of three subtypes, including α1A-, α1B-, and α1D-adrenergic. Naftopidil is subtype-selective for the α1D-adrenoceptor with approximately 3- and 17-fold higher affinity than for the α1A- and α1B-adrenoceptor subtypes, respectively. In Japan, naftopidil is used to treat lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). Recently, it has been reported that naftopidil suppresses human prostate tumor growth. (The product is for research purpose only.)
References
- Naftopidil, a novel α1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human α1-adrenoceptors
- Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats
- The role of naftopidil in the management of benign prostatic hyperplasia (a review)
- Naftopidil, a selective α-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest
- Naftopidil, a selective α1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma
- Determination of naftopidil enantiomers in rat plasma using chiral solid phases and pre-column derivatization high-performance liquid chromatography
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.